# OnCo record essa-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/essa-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "essa-pharma" ;
  schema:name "ESSA Pharma"@en ;
  schema:description "ESSA Pharma developed masofaniten, an AR N-terminal-domain inhibitor whose phase 2 was stopped for futility in 2024-25."@en ;
  schema:url <https://onco.cc/companies/essa-pharma/>, <https://essapharma.com> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://essapharma.com> ;
  onco:tag "failed-so-far" ;
  schema:addressCountry "CA" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/hormonal/> ;
  onco:drugs <https://onco.cc/drugs/masofaniten/> .